Arteriosclerosis and Thrombosis, Vol 13, 1253-1260, Copyright © 1993 by American Heart Association

ARTICLES

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology

NP Dudman, DE Wilcken, J Wang, JF Lynch, D Macey and P Lundberg
Department of Medicine, University of New South Wales, Prince Henry Hospital, Little Bay, NSW, Australia.

Mild homocysteinemia occurs surprisingly often in patients with premature vascular disease. We studied the possible enzymatic sources of this mild hyperhomocysteinemia and the control of homocysteine levels in plasma by treatment of patients with the cofactors and cosubstrates of homocysteine catabolism. We assessed homocysteine metabolism in 131 patients who had premature disease in their coronary, peripheral, or cerebrovascular circulation by using a standard oral methionine-load test. Impaired homocysteine metabolism occurred in 28 patients. We assayed levels of the primary enzymes of homocysteine catabolism in cultured skin fibroblast extracts from 15 of these 28 patients. The patients' cystathionine beta-synthase levels (3.68 +/- 2.52 nmol/h per milligram of cell protein, mean +/- SD) were markedly depressed compared with those from 31 healthy adult control subjects (7.61 +/- 4.49, P < .001). The patients' levels of 5- methyltetrahydrofolate: homocysteine methyltransferase were normal. While betaine: homocysteine methyltransferase was not expressed in skin fibroblasts, 24-hour urinary betaine and N,N-dimethylglycine measurements were consistent with normal or enhanced remethylation of homocysteine by betaine: homocysteine methyltransferase in the 13 patients tested. When treated daily with choline and betaine, pyridoxine, or folic acid, there was a normalization of the postmethionine plasma homocysteine level in 16 of 19 patients. Our results indicate that mild homocysteinemia in premature vascular disease may be caused by either a folate deficiency or deficiencies in cystathionine beta-synthase activity. It does not necessarily involve deficiencies of either 5-methyltetrahydrofolate:homocysteine methyltransferase or betaine:homocysteine methyltransferase. Effective treatment regimens are also defined.

This article has been cited by other articles:

				W. Atkinson, J. Elmslie, M. Lever, S. T Chambers, and P. M George Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects Am. J. Clinical Nutrition, March 1, 2008; 87(3): 577 - 585. [Abstract] [Full Text] [PDF]

				A. L. Buchman, M. E. Ament, D. J. Jenden, and C. Ahn Choline Deficiency Is Associated With Increased Risk for Venous Catheter Thrombosis JPEN J Parenter Enteral Nutr, July 1, 2006; 30(4): 317 - 320. [Abstract] [Full Text] [PDF]

				M. R Olthof, E. J Brink, M. B Katan, and P. Verhoef Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men Am. J. Clinical Nutrition, July 1, 2005; 82(1): 111 - 117. [Abstract] [Full Text] [PDF]

				S. A. Craig Betaine in human nutrition Am. J. Clinical Nutrition, September 1, 2004; 80(3): 539 - 549. [Abstract] [Full Text] [PDF]

				O. Bleie, H. Refsum, P. M. Ueland, S. E. Vollset, A. B. Guttormsen, E. Nexo, J. Schneede, J. E. Nordrehaug, and O. Nygard Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention Am. J. Clinical Nutrition, September 1, 2004; 80(3): 641 - 648. [Abstract] [Full Text] [PDF]

				P. I. Holm, O. Bleie, P. M. Ueland, E. A. Lien, H. Refsum, J. E. Nordrehaug, and O. Nygard Betaine as a Determinant of Postmethionine Load Total Plasma Homocysteine Before and After B-Vitamin Supplementation Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 301 - 307. [Abstract] [Full Text]

				Homocysteine Studies Collaboration Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis JAMA, October 23, 2002; 288(16): 2015 - 2022. [Abstract] [Full Text] [PDF]

				T. B. Shea, E. Rogers, J. Auer, R. Berent, B. Eber, S. Seshadri, and P. A. Wolf Homocysteine and Dementia N. Engl. J. Med., June 20, 2002; 346(25): 2007 - 2008. [Full Text] [PDF]

				E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70. [Abstract] [Full Text] [PDF]

				G. BESSEDE, C. MIGUET, P. GAMBERT, D. NEEL, and G. LIZARD Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to {gamma}-glutamyl transpeptidase activity FASEB J, September 1, 2001; 15(11): 1927 - 1940. [Abstract] [Full Text] [PDF]

				J. B. Meigs, P. F. Jacques, J. Selhub, D. E. Singer, D. M. Nathan, N. Rifai, R. B. D'Agostino Sr., and P. W.F. Wilson Fasting Plasma Homocysteine Levels in the Insulin Resistance Syndrome: The Framingham Offspring Study Diabetes Care, August 1, 2001; 24(8): 1403 - 1410. [Abstract] [Full Text] [PDF]

				M. J. MacCoss, N. K. Fukagawa, and D. E. Matthews Measurement of intracellular sulfur amino acid metabolism in humans Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E947 - E955. [Abstract] [Full Text] [PDF]

				M. C McKinley, H. McNulty, J. McPartlin, J. Strain, K. Pentieva, M. Ward, D. G Weir, and J. M Scott Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete Am. J. Clinical Nutrition, April 1, 2001; 73(4): 759 - 764. [Abstract] [Full Text] [PDF]

				J. K. Kern, V. S. Miller, L. Cauller, R. Kendall, J. Mehta, and M. Dodd Effectiveness of N,N-Dimethylglycine in Autism and Pervasive Developmental Disorder J Child Neurol, March 1, 2001; 16(3): 169 - 173. [Abstract] [PDF]

				C G Hanratty, L T McGrath, D F McAuley, I S Young, and G D Johnston The effects of oral methionine and homocysteine on endothelial function Heart, March 1, 2001; 85(3): 326 - 330. [Abstract] [Full Text]

				W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual? Arch Intern Med, February 28, 2000; 160(4): 422 - 434. [Abstract] [Full Text] [PDF]

				V. Fonseca, S. C. Guba, and L. M. Fink Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis Endocr. Rev., October 1, 1999; 20(5): 738 - 759. [Abstract] [Full Text]

				B. Kristensen, J. Malm, T. K. Nilsson, J. Hultdin, B. Carlberg, G. Dahlen, and T. Olsson Hyperhomocysteinemia and Hypofibrinolysis in Young Adults With Ischemic Stroke Stroke, May 1, 1999; 30(5): 974 - 980. [Abstract] [Full Text] [PDF]

				S. H. Moolenaar, J. Poggi-Bach, U. F.H. Engelke, J. M.B. Corstiaensen, A. Heerschap, J. G.N. de Jong, B. A. Binzak, J. Vockley, and R. A. Wevers Defect in Dimethylglycine Dehydrogenase, a New Inborn Error of Metabolism: NMR Spectroscopy Study Clin. Chem., April 1, 1999; 45(4): 459 - 464. [Abstract] [Full Text] [PDF]

				D. L. Harmon, R. M. Doyle, R. Meleady, M. Doyle, D. C. Shields, R. Barry, D. Coakley, I. M. Graham, and A. S. Whitehead Genetic Analysis of the Thermolabile Variant of 5,10-Methylenetetrahydrofolate Reductase as a Risk Factor for Ischemic Stroke Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 208 - 211. [Abstract] [Full Text] [PDF]

				H. Morita, H. Kurihara, T. Sugiyama, C. Hamada, Y. Kurihara, T. Shindo, Y. Oh-hashi, and Y. Yazaki Polymorphism of the Methionine Synthase Gene : Association With Homocysteine Metabolism and Late-Onset Vascular Diseases in the Japanese Population Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 298 - 302. [Abstract] [Full Text] [PDF]

				M. D. Laryea, F. Steinhagen, S. Pawliczek, and U. Wendel Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine Clin. Chem., September 1, 1998; 44(9): 1937 - 1941. [Abstract] [Full Text] [PDF]

				G. N. Welch and J. Loscalzo Homocysteine and Atherothrombosis N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050. [Full Text] [PDF]

				K. Robinson, K. Arheart, H. Refsum, L. Brattstrom, G. Boers, P. Ueland, P. Rubba, R. Palma-Reis, R. Meleady, L. Daly, et al. Low Circulating Folate and Vitamin B6 Concentrations : Risk Factors for Stroke, Peripheral Vascular Disease, and Coronary Artery Disease Circulation, February 10, 1998; 97(5): 437 - 443. [Abstract] [Full Text] [PDF]

				K. Kottke-Marchant, R. Green, D. W. Jacobsen, A. Gupta, S. R. Savon, M. Secic, and K. Robinson High Plasma Homocysteine: A Risk Factor for Arterial and Venous Thrombosis in Patients with Normal Coagulation Profiles Clinical and Applied Thrombosis/Hemostasis, October 1, 1997; 3(4): 239 - 244. [Abstract] [PDF]

				A. D'Angelo and J. Selhub Homocysteine and Thrombotic Disease Blood, July 1, 1997; 90(1): 1 - 11. [Full Text] [PDF]

				H. Morita, J.-i. Taguchi, H. Kurihara, M. Kitaoka, H. Kaneda, Y. Kurihara, K. Maemura, T. Minamino, M. Ohno, K. Yamaoki, et al. Genetic Polymorphism of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) as a Risk Factor for Coronary Artery Disease Circulation, April 15, 1997; 95(8): 2032 - 2036. [Abstract] [Full Text]

				R. A. Morrison, A. McGrath, G. Davidson, J. J. Brown, G. D. Murray, and A. F. Lever Low Blood Pressure in Down's Syndrome: A Link With Alzheimer's Disease? Hypertension, October 1, 1996; 28(4): 569 - 575. [Abstract] [Full Text]

				D. E.L. Wilcken, X. L. Wang, A. S. Sim, and R. M. McCredie Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C677T Mutation Arterioscler Thromb Vasc Biol, July 1, 1996; 16(7): 878 - 882. [Abstract] [Full Text]

				F. M.T. Loehrer, C. P. Angst, W. E. Haefeli, P. P. Jordan, R. Ritz, and B. Fowler Low Whole-Blood S-Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 727 - 733. [Abstract] [Full Text]

				C. J. Boushey, S. A. A. Beresford, G. S. Omenn, and A. G. Motulsky A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease: Probable Benefits of Increasing Folic Acid Intakes JAMA, October 4, 1995; 274(13): 1049 - 1057. [Abstract] [PDF]

				P. N. Hopkins, L. L. Wu, J. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1314 - 1320. [Abstract] [Full Text]

				A. Lindgren, L. Brattstrom, B. Norrving, B. Hultberg, A. Andersson, and B. B. Johansson Plasma Homocysteine in the Acute and Convalescent Phases After Stroke Stroke, May 1, 1995; 26(5): 795 - 800. [Abstract] [Full Text]